Medtronic: annual targets tightened up again
(CercleFinance.com) - On the occasion of its quarterly publication, Medtronic now targets non-GAAP EPS of between $5.
44 and $5.50 for FY 2024-25, compared with its previous target range of $5.42 to $5.50.
The medical equipment supplier has also raised its guidance for organic annual revenue growth to between 4.75% and 5%, from the 4.5% to 5% range provided three months ago.
For Q2, Medtronic reported non-GAAP EPS of $1.26, up 1% (+8% at constant exchange rates), on revenues of $8.4bn, up 5.3% (+5% organic).
Copyright (c) 2024 CercleFinance.com. All rights reserved.
44 and $5.50 for FY 2024-25, compared with its previous target range of $5.42 to $5.50.
The medical equipment supplier has also raised its guidance for organic annual revenue growth to between 4.75% and 5%, from the 4.5% to 5% range provided three months ago.
For Q2, Medtronic reported non-GAAP EPS of $1.26, up 1% (+8% at constant exchange rates), on revenues of $8.4bn, up 5.3% (+5% organic).
Copyright (c) 2024 CercleFinance.com. All rights reserved.